Cmc Pharmaceuticals
Developing new and better drug formulations.
Based in OH
🤖
AI Overview
With $390K in lobbying spend across 12 quarterly filings, Cmc Pharmaceuticals is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2023 to 2025.
$390K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $70K |
| 2024 | $160K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense, Government Issues
- •Support for DOD Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.
- •Support for DOD Chemical Biological Defense medical countermeasures pre and post exposure protection funding.
- •Support for DOD Chemical Biological Defense medical countermeasures pre and post exposure protection policy.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.